How many drugs treat backache?

Drug Landscape tracks 7 marketed treatments for backache (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/backache.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

backache — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

backache (disease) competitive landscape: 7 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

7 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating backache, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Qutenza	CAPSAICIN	Averitas	capsaicin	Transient receptor potential cation channel subfamily V member 1	2009-01-01
Salonpas	METHYL SALICYLATE	Hisamitsu Pharm Co	methyl salicylate		2008-01-01
Acetaminophen	Paracetamol	Polymedica	acetaminophen	Transient receptor potential cation channel subfamily V member 4	1968-01-01
Soma	CARISOPRODOL	Mylan Speciality Lp	Muscle Relaxant [EPC]		1959-01-01
Norgesic	acetylsalicylic acid	Endo	centrally acting muscle relaxant with anticholinergic properties	reticular formation (brain stem)	1950-01-01
Norgesic	caffeine	Hikma	Central Nervous System Stimulant [EPC]	Adenosine receptor A2a	1948-01-01
MEDIQUE APAP EXTRA STRENGTH acetaminophen tablet, film coated	APAP	HF Acquisition Co LLC, DBA HealthFirst

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 4 drugs in backache
Averitas · 1 drug in backache
Endo · 1 drug in backache
HF Acquisition Co LLC, DBA HealthFirst · 1 drug in backache
Hikma · 1 drug in backache
Hisamitsu Pharm Co · 1 drug in backache
Mylan Speciality Lp · 1 drug in backache
Polymedica · 1 drug in backache

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in backache:

Cite this brief

Drug Landscape (2026). backache — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/backache. Accessed 2026-06-10.

backache full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing